AGL 40.05 Increased By ▲ 0.05 (0.13%)
AIRLINK 127.05 Increased By ▲ 0.01 (0.01%)
BOP 6.57 Decreased By ▼ -0.10 (-1.5%)
CNERGY 4.53 Increased By ▲ 0.02 (0.44%)
DCL 8.44 Decreased By ▼ -0.11 (-1.29%)
DFML 41.59 Increased By ▲ 0.15 (0.36%)
DGKC 86.66 Decreased By ▼ -0.19 (-0.22%)
FCCL 32.20 Decreased By ▼ -0.08 (-0.25%)
FFBL 65.10 Increased By ▲ 0.30 (0.46%)
FFL 10.15 Decreased By ▼ -0.10 (-0.98%)
HUBC 110.49 Increased By ▲ 0.92 (0.84%)
HUMNL 14.69 Increased By ▲ 0.01 (0.07%)
KEL 5.16 Increased By ▲ 0.11 (2.18%)
KOSM 7.21 Decreased By ▼ -0.25 (-3.35%)
MLCF 41.45 Increased By ▲ 0.07 (0.17%)
NBP 59.81 Decreased By ▼ -0.60 (-0.99%)
OGDC 193.79 Increased By ▲ 3.69 (1.94%)
PAEL 28.00 Increased By ▲ 0.17 (0.61%)
PIBTL 7.90 Increased By ▲ 0.07 (0.89%)
PPL 150.06 No Change ▼ 0.00 (0%)
PRL 26.72 Decreased By ▼ -0.16 (-0.6%)
PTC 16.10 Increased By ▲ 0.03 (0.19%)
SEARL 78.00 Decreased By ▼ -8.00 (-9.3%)
TELE 7.38 Decreased By ▼ -0.33 (-4.28%)
TOMCL 35.40 Decreased By ▼ -0.01 (-0.03%)
TPLP 7.86 Decreased By ▼ -0.26 (-3.2%)
TREET 15.90 Decreased By ▼ -0.51 (-3.11%)
TRG 52.75 Decreased By ▼ -0.54 (-1.01%)
UNITY 26.50 Increased By ▲ 0.34 (1.3%)
WTL 1.27 Increased By ▲ 0.01 (0.79%)
BR100 9,949 Increased By 65.7 (0.66%)
BR30 30,910 Increased By 309.7 (1.01%)
KSE100 94,021 Increased By 665.8 (0.71%)
KSE30 29,143 Increased By 212 (0.73%)

KARACHI: As Pakistan’s pharmaceutical sector aims to leverage its potential for increased exports, industry experts are calling for government support to create an enabling environment for growth.

Key officials express that with the right policy framework, exports could rise dramatically from the current levels. Industry leaders pointed out that while sectors such as textiles, carpets, leather, sports goods, and surgical instruments receive preferential treatment, pharmaceuticals have not enjoyed similar benefits.

The current export facilitation framework appears to favour established sectors based on past performance, overlooking the substantial potential of pharmaceuticals, which could significantly contribute to foreign exchange inflows.

Pakistan Pharma Summit 2024: experts gather with aim to chart path for growth in pharmaceutical industry

Currently, Pakistan’s pharmaceutical industry has performed well in specific markets. Countries like Uzbekistan, Nigeria, and Afghanistan are among those where pharmaceuticals rank as major export commodities.

“Even based on existing performance, there are several countries where pharmaceutical products from Pakistan are the largest exported commodity,” underscoring the sector’s robust international footprint.

A former chairman of the Pakistan Pharmaceutical Manufacturers’ Association (PPMA) has already stated that the country’s pharmaceutical exports could reach $3 billion within the next five years if the government prioritises the sector in its export policies. In contrast, Indian pharmaceutical exports were projected to hit $28 billion, while Pakistan’s exports hit a historic high of just over $341 million in 2023-24.

Experts believed that a structured market development assistance (MDA) programme similar to India’s initiative could provide necessary support to local pharmaceutical companies.

Furthermore, they advocated for a thorough assessment of local API production capabilities before imposing duties, arguing that such measures can ensure affordability and competitiveness of Pakistani pharmaceutical products. The sector also faces challenges related to maintaining a stable supply chain and reliable raw material procurement, which are key to securing lasting agreements in foreign markets. As observed, foreign markets typically demand long-term contracts of up to seven years, creating a need for predictability in supply chains and procurement strategies.

With the government exploring avenues to generate foreign exchange and reduce dependency on debt, focusing on non-debt creating exports is critical. Analysts point out that despite significant rupee depreciation over recent years, the anticipated growth in exports has not materialized, suggesting that new strategies are necessary to unlock Pakistan’s export potential.

Copyright Business Recorder, 2024

Comments

200 characters
Obaid Ali Nov 13, 2024 08:43pm
Functioning based on the incorrect hypothesis would be wrong. Don't be victim of ignorant. First and last word is Quality. No body ask anybody to manufacture poor quality drug. Be honest please
thumb_up Recommended (0) reply Reply